Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
TUESDAY, June 25, 2019 -- Survivors of childhood low-grade gliomas treated with radiotherapy have poorer neuropsychological and socioeconomic-status (SES) outcomes, according to a study published online June 24 in Cancer.
M. Douglas Ris, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 25, 2019 Category: Pharmaceuticals Source Type: news
Computer - Assisted Diagnosis Aids Detection of Glioma Growth
Physicians using CAD can detect growth of low - grade gliomas at significantly smaller volumes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 20, 2019 Category: Cancer & Oncology Tags: Neurology, Oncology, Radiology, Journal, Source Type: news
Computer-Assisted Diagnosis Aids Detection of Glioma Growth
THURSDAY, June 20, 2019 -- Computer-assisted diagnosis (CAD) can help physicians detect growth of low-grade gliomas, according to a study published online May 28 in PLOS Medicine.
Hassan M. Fathallah-Shaykh, M.D., from the University of Alabama at... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 20, 2019 Category: Pharmaceuticals Source Type: news
Blue Earth highlights SNMMI 2019 presentations
Molecular imaging firm Blue Earth Diagnostics is touting 16 presentations involving...Read more on AuntMinnie.comRelated Reading:
Blue Earth touts presentations at AUA 2019
Blue Earth study reports Axumin can aid glioma diagnosis
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2019 Category: Radiology Source Type: news
Surgical Smoke Helps ID Brain Tumors
A team at Tampere University, Finland has developed a technique using surgical smoke that allows neurosurgeons to ID cancerous tissue during surgery.
A new method developed by researchers at Tampere University in Finland helps analyze surgical smoke to distinguish between malignant tissue and health tissue. The researcher’s work was recently published in the Journal of Neurosurgery.
The technology is based on differential mobility spectrometry, wherein flue gas ions are fed into an electric field. The distribution of ions in the electric field is tissue-specific, and the tissue can be identified on the ba...
Source: MDDI - June 14, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
03.06.19: Not intended for U.S. and UK Media - Annual Meeting of the American Society of Clinical Oncology (ASCO) 2019:
New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019In five TRK fusion cancer patients with brain metastases across different tumor histologies, the overall response rate was 60%, with disease control achieved in all patients / In 14 adult and pediatric patients with TRK fusion cancer with primary central nervous system (CNS) tumors (including high grade gliomas), the overall response rate was 36% including two complete responses / 71% of evaluable patients with primary CNS tumors experienced disease control for 24 weeks or more / First pros...
Source: Bayer IR Newsfeed: Events - June 4, 2019 Category: Pharmaceuticals Source Type: news
New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019 (for specialized target groups only)
In five TRK fusion cancer patients with brain metastases across different tumor histologies, the overall response rate was 60%, with disease control achieved in all patients / In 14 adult and pediatric patients with TRK fusion cancer with primary central nervous system (CNS) tumors (including high grade gliomas), the overall response rate was 36% including two complete responses / 71% of evaluable patients with primary CNS tumors experienced disease control for 24 weeks or more / First prospective analysis of the activity of larotrectinib in patients with TRK fusion cancer and intracranial disease, including first data eve...
Source: Bayer Company News - June 3, 2019 Category: Pharmaceuticals Source Type: news
Blue Earth touts presentations at AUA 2019
Molecular imaging firm Blue Earth Diagnostics is highlighting several presentations...Read more on AuntMinnie.comRelated Reading:
Blue Earth study reports Axumin can aid glioma diagnosis
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines
Blue Earth highlights Axumin clinical results at ASTRO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 6, 2019 Category: Radiology Source Type: news
Mother, 19, who was diagnosed with untreatable brain cancer months before giving birth dies
Dana Scatton, of Pennsylvania, was seven months pregnant in December 2017 when a brain scan revealed she had diffuse intrinsic pontine glioma (DIPG). (Source: the Mail online | Health)
Source: the Mail online | Health - April 25, 2019 Category: Consumer Health News Source Type: news
Virtual reality engages patients more than CT, booklets
Patients with an abdominal aortic aneurysm were more engaged and had a better...Read more on AuntMinnie.comRelated Reading:
4 practical applications of VR, AR in radiology
SIR: Virtual reality beats fluoroscopy for catheter placement
VR, AR elevate radiologists' value in future of medicine
Virtual reality may help plan, guide glioma resection
VR software may increase MRI segmentation efficiency (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2019 Category: Radiology Source Type: news
How Common Are Brain Tumors Seen in Spasmus Nutans?
Discussion
Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus).
Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion
Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus).
Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
How cost-effective is intraoperative MRI for gliomas?
Using a simulated clinical decision analysis model, researchers from the University...Read more on AuntMinnie.comRelated Reading:
Workflow optimization cuts MRI turnaround time
Imaging analytics platform optimizes MRI operations
MRA is cost-effective for kidney disease-related aneurysms
Study reveals steep cost of delaying stroke treatment
MRI for knee pain adds cost with negligible benefit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2019 Category: Radiology Source Type: news
Clinical trial finds therapy to be well-tolerated in patients with aggressive brain tumour
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades. (Source: World Pharma News)
Source: World Pharma News - March 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
SIR: Virtual reality beats fluoroscopy for catheter placement
Virtual reality may be a safer, more time-efficient alternative to conventional...Read more on AuntMinnie.comRelated Reading:
VR, AR elevate radiologists' value in future of medicine
Virtual reality may help plan, guide glioma resection
3D printing gives pediatric heart surgery a boost
Virtual reality, 3D printing resolve obscure lung cancer
Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2019 Category: Radiology Source Type: news
